Search for: "New York Times Company et al v. U.S. Food and Drug Administration" Results 1 - 20 of 32
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Aug 2019, 1:26 pm by Bill Marler
Thanks to the New York Times and Matt Richtel for “Tainted Pork, Ill Consumers and an Investigation Thwarted. [read post]
29 Mar 2012, 12:10 pm by Tom Lamb
  These bills would permit manufacturers of generic drugs to provide additional warnings about their drugs in the same manner that the Food and Drug Administration (FDA) allows for brand name manufacturers. (5/15/12) _____________________________________________________________________ The Pliva, Inc., et al. v. [read post]
23 Jul 2012, 12:00 pm by Lucas A. Ferrara, Esq.
The pills were ultimately sold to wholesale prescription drug distribution companies ("corrupt distribution companies"), which then sold them to pharmacies and to other wholesale prescription distribution drug companies across the United States. [read post]
17 Jul 2014, 10:58 am
It arises out of the filing by Defendant First Time US Generics LLC ("FTUG") of an Abbreviated New Drug Application ("ANDA") with the United States Food and Drug Administration ("FDA") seeking approval to manufacture and sell generic versions of two of Lilly's pharmaceutical products, Effient® 5mg and Effient® 10mg tablets, prior to the expiration of Daiichi Sankyo's and Ube's U.S.… [read post]
21 Jun 2013, 6:43 pm by Schachtman
Martin, et al., New York Evidence Handbook  318 (2d ed. 2002)). [read post]
9 Jan 2014, 1:37 pm
Md. 2012) (same); New York State Pesticide Coalition, Inc. v. [read post]
19 Jul 2022, 2:59 pm by Kevin LaCroix
  FACT: As discussed in more detail below, statements of opinion will be protected under the U.S. [read post]
23 Jul 2020, 4:00 am by Jon L. Gelman
The comparison offers insight into avoiding past economic, administrative and benefit delivery pitfalls. [read post]